Magnetar Financial’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,504
Closed -$205K – 1800
2026
Q2
$205K Buy
+11,504
New +$206K ﹤0.01% 933
2026
Q1
– Sell
-17,493
Closed -$472K – 1467
2025
Q4
$472K Buy
+17,493
New +$493K ﹤0.01% 573

Other funds holding CAI

Magnetar Financial's CAI Position: Q3 2026 in Review

Magnetar Financial sold out of Caris Life Sciences (CAI) in Q3 2026, closing a stake of 11,504 shares — an estimated $205K sold.

Magnetar Financial first reported a position in CAI in Q4 2025 and held it in 2 quarters. The position peaked at $472K in Q4 2025. 326 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Magnetar Financial reported no remaining Caris Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Magnetar Financial sold 11,504 Caris Life Sciences shares in Q3 2026, an estimated $205K.
  • Magnetar Financial first reported a position in Caris Life Sciences in Q4 2025 and held it in 2 quarters.
  • Magnetar Financial's Caris Life Sciences position peaked at $472K in Q4 2025.
  • 326 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.